BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28382958)

  • 1. Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients.
    Borghi C; Acelajado MC; Gupta Y; Jain S
    J Hum Hypertens; 2017 Oct; 31(10):605-610. PubMed ID: 28382958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of nebivolol vs. metoprolol on microvascular function in hypertensive humans.
    Velasco A; Solow E; Price A; Wang Z; Arbique D; Arbique G; Adams-Huet B; Schwedhelm E; Lindner JR; Vongpatanasin W
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H118-24. PubMed ID: 27199121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults.
    Werner TJ; Boutagy NE; Osterberg KL; Rivero JM; Davy KP
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):285-92. PubMed ID: 24265181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study.
    Vaz-de-Melo RO; Giollo-Júnior LT; Martinelli DD; Moreno-Júnior H; Mota-Gomes MA; Cipullo JP; Yugar-Toledo JC; Vilela-Martin JF
    Sao Paulo Med J; 2014; 132(5):290-6. PubMed ID: 25054966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol: impact on cardiac and endothelial function and clinical utility.
    Toblli JE; DiGennaro F; Giani JF; Dominici FP
    Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparsion of central aortic pressure to brachial artery pressure in hypertensive patients on drug treatment: An observational study.
    Baba BA; Johan PT; Mohan JC
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S208-S212. PubMed ID: 30595260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.
    Agnoletti D; Zhang Y; Borghi C; Blacher J; Safar ME
    Am J Hypertens; 2013 Aug; 26(8):1045-52. PubMed ID: 23736112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.
    Coats A; Jain S
    J Hum Hypertens; 2017 Jun; 31(6):376-381. PubMed ID: 28252041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension.
    Li B; Zhang Q; Zhang H; Wang C; Xiu R
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32342981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
    Vitale C; Marazzi G; Iellamo F; Spoletini I; Dall'Armi V; Fini M; Volterrani M
    Int J Cardiol; 2012 Mar; 155(2):279-84. PubMed ID: 22078979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Nebivolol Pharmacology and Clinical Evidence.
    Fongemie J; Felix-Getzik E
    Drugs; 2015 Aug; 75(12):1349-71. PubMed ID: 26177892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A; Feely J
    Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of obstructive sleep apnea on the response to hypertension therapy.
    Ziegler MG; Milic M; Lu X; Gharaibeh M; Elayan H
    Clin Exp Hypertens; 2017; 39(5):409-415. PubMed ID: 28557555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Celiprolol and Bisoprolol on Blood Pressure, Vascular Stiffness, and Baroreflex Sensitivity.
    Eguchi K; Hoshide S; Kario K
    Am J Hypertens; 2015 Jul; 28(7):858-67. PubMed ID: 25577782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
    Georgianos PI; Agarwal R
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):639-45. PubMed ID: 25784174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.
    Eeftinck Schattenkerk DW; van den Bogaard B; Cammenga M; Westerhof BE; Stroes ES; van den Born BJ
    J Hypertens; 2013 Dec; 31(12):2447-54. PubMed ID: 24126713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.